Federated Hermes Inc. Has $410,000 Holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Federated Hermes Inc. boosted its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 3,047.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 89,665 shares of the company's stock after buying an additional 86,816 shares during the period. Federated Hermes Inc.'s holdings in Aveanna Healthcare were worth $410,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. KLP Kapitalforvaltning AS purchased a new position in Aveanna Healthcare during the 4th quarter valued at about $35,000. Catalyst Funds Management Pty Ltd boosted its holdings in shares of Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after purchasing an additional 9,000 shares during the period. Arizona State Retirement System purchased a new position in Aveanna Healthcare during the fourth quarter valued at approximately $64,000. Dynamic Technology Lab Private Ltd acquired a new position in Aveanna Healthcare in the 4th quarter valued at approximately $65,000. Finally, EntryPoint Capital LLC acquired a new stake in shares of Aveanna Healthcare during the 4th quarter valued at $68,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Price Performance

Shares of AVAH stock traded up $0.22 during trading on Wednesday, reaching $4.59. The company had a trading volume of 22,630 shares, compared to its average volume of 256,205. The firm's 50 day simple moving average is $4.75 and its two-hundred day simple moving average is $4.91. Aveanna Healthcare Holdings Inc. has a one year low of $2.15 and a one year high of $6.19. The company has a market capitalization of $895.48 million, a PE ratio of -13.50 and a beta of 1.99.

Analyst Ratings Changes

Several brokerages recently issued reports on AVAH. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th. UBS Group raised their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a "sell" rating in a research note on Friday, March 14th.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total value of $339,217.64. Following the transaction, the insider now directly owns 1,453,948 shares in the company, valued at approximately $8,011,253.48. The trade was a 4.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 67,412 shares of company stock worth $372,142 over the last 90 days. Insiders own 7.80% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.